Improvement of hepatic steatosis in type 2 diabetic patients treated with a combination of pioglitazone and insulin

被引：0
|
作者：
Zib, Ivana
Salas, Naomi
Raskin, Philip
Szczepaniak, Lidia S.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [21] Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
    Miyazaki, Y
    Mandarino, LJ
    Defronzo, R
    DIABETES, 2004, 53 : A138 - A138
  • [22] Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
    Miyazaki, Y
    Mahankali, A
    Wajcberg, E
    Bajaj, M
    Mandarino, LJ
    DeFronzo, RA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09): : 4312 - 4319
  • [23] Combination of Insulin with Pioglitazone in Patients with Type 2 Diabetes-The Impact of Disease Duration
    Grueneberg, Martin
    Heddaeus, Helmut
    Kroeger, Jens
    Schoenauer, Martin
    Karagiannis, Efstrathios
    Lundershausen, Rainer
    DIABETES, 2009, 58 : A542 - A542
  • [24] Clinical investigation of the effects of pioglitazone on the improvement of insulin resistance and blood pressure in Type 2-diabetic patients undergoing hemodialysis
    Abe, M.
    Okada, K.
    Kikuchi, F.
    Matsumoto, K.
    CLINICAL NEPHROLOGY, 2008, 70 (03) : 220 - 228
  • [25] Focal reversible hepatic steatosis in type 1 diabetic patients treated by intraperitoneal insulinotherapy by implantable pump
    Riveline, J. P.
    Jeandidier, N.
    Pinget, M.
    Charpentier, G.
    Franc, S.
    Dardari, D.
    Meyer, L.
    DIABETES & METABOLISM, 2008, 34 : A88 - A88
  • [26] Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice
    Kim, Young-Je
    Jung, Un Ju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [27] Assessment of hepatic insulin action in obese type 2 diabetic patients
    Staehr, P
    Hother-Nielsen, O
    Levin, K
    Holst, JJ
    Beck-Nielsen, H
    DIABETES, 2001, 50 (06) : 1363 - 1370
  • [28] Validity of hepatic steatosis indices for prediction of non-alcoholic hepatic steatosis in type 1 diabetic patients
    Sokolovska, J.
    Sviklane, L.
    Olmane, E.
    Dzerve, Z.
    Kupcs, K.
    DIABETOLOGIA, 2017, 60 : S573 - S573
  • [29] Combination Therapy of Insulin and Liraglutide in Type 2 Diabetic Patients in Japan
    Yoshikawa, Yuichiro
    Kagaya, Hiroki
    Hirai, Keiji
    Kawakami, Soshi
    Imamura, Shigeki
    Hirai, Aizan
    DIABETES, 2014, 63 : A608 - A608
  • [30] Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients
    N. Güvener
    O. Gedik
    Acta Diabetologica, 1999, 36 : 93 - 97
12345